Academic trial suggests modest GLP-1 effect in Parkinson's disease, but questions remain
New data from a French academic trial published in the New England Journal of Medicine on Wednesday suggest the potential for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
